Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of either sex, aged 5 18 years. 2.Patients presenting with classical signs and symptoms of Dadru (Tinea Corporis).
Exclusion criteria
Exclusion criteria: 1.Patients below 5 years or above 18 years of age. 2.Patients with other associated skin disorders such as eczema, secondary bacterial infections, etc. 3.Patients with a history of long-term steroid or cytotoxic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of Kusthadi Lepa in comparison to Dadruhar Lepa along with Manjishthadi syrup in the management of Dadru (Tinea Corporis) in children.Timepoint: 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To assess the physicochemical parameters of Kusthadi Lepa , Dadruhar Lepa and Manjisthadi syrup. 2.To evaluate the ability of the formulation to reduce or subside classical symptoms of Dadru. 3.To evaluate the safety, sustainability, and adverse drug reactions (ADRs) of the trial drugs.Timepoint: 60 days | — |
Countries
India
Contacts
DSRRAU,PGIA,JODHPUR